Pyrazolo-triazolo-pyrimidines as adenosine receptor antagonists: A complete structure–activity profile
Open Access
- 14 November 2006
- journal article
- research article
- Published by Springer Nature in Purinergic Signalling
- Vol. 3 (3) , 183-193
- https://doi.org/10.1007/s11302-006-9027-x
Abstract
In the last 5 years, many efforts have been conducted searching potent and selective human A3 adenosine antagonists. In this field several different classes of compounds, possessing very good affinity (nM range) and with a broad range of selectivity, have been proposed. Recently, our group synthesized a new series of pyrazolo-triazolo-pyrimidines bearing different substitutions at the N5 and N8 positions, which have been described as highly potent and selective human A3 adenosine receptor antagonists. The present review summarizes available data and provides an overview of the structure–activity relationships found for this class of human A3 adenosine receptor antagonists.Keywords
This publication has 33 references indexed in Scilit:
- Design, Synthesis, and Biological Evaluation of C9- and C2-Substituted Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as New A2Aand A3Adenosine Receptors AntagonistsJournal of Medicinal Chemistry, 2003
- Pyrazolo[4,3‐e]1,2,4‐triazolo[1,5‐c]pyrimidine derivatives as adenosine receptor ligands: A starting point for searching A2B adenosine receptor antagonistsDrug Development Research, 2001
- Design, Radiosynthesis, and Biodistribution of a New Potent and Selective Ligand for in Vivo Imaging of the Adenosine A2A Receptor System Using Positron Emission TomographyJournal of Medicinal Chemistry, 2000
- Crystal Structure of Rhodopsin: A G Protein-Coupled ReceptorScience, 2000
- Derivatives of the Triazoloquinazoline Adenosine Antagonist (CGS 15943) Having High Potency at the Human A2Band A3Receptor SubtypesJournal of Medicinal Chemistry, 1998
- Design, Synthesis, and Biological Evaluation of a Second Generation of Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as Potent and Selective A2A Adenosine Receptor AntagonistsJournal of Medicinal Chemistry, 1998
- Mutagenesis Reveals Structure−Activity Parallels between Human A2AAdenosine Receptors and Biogenic Amine G Protein-Coupled ReceptorsJournal of Medicinal Chemistry, 1997
- Derivatives of the Triazoloquinazoline Adenosine Antagonist (CGS15943) Are Selective for the Human A3Receptor SubtypeJournal of Medicinal Chemistry, 1996
- Synthesis of new pyrazolo[4,3-e]1,2,4-triazolo[1,5-c] pyrimidine and 1,2,3-triazolo[4,5-e]1,2,4-triazolo[1,5-c] pyrimidine displaying potent and selective activity as A2a adenosine receptor antagonists.Bioorganic & Medicinal Chemistry Letters, 1994
- Synthesis of imidazo[1,2-c]pyrazolo[4,3-e]pyrimidines, pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidines and 1,2,4-triazolo[5,1-i]purines: new potent adenosine A2 receptor antagonistsEuropean Journal of Medicinal Chemistry, 1993